21 Jan 2026

Vitrue Health Report: The State of MSK in the Workplace 2025

This report uses aggregated data from more than 112,000 employees, and finds that musculoskeletal pain is a commercial risk as well as a wellbeing concern.

It highlights the direct and indirect costs of MSK, why the gender pain gap demands a more inclusive approach and what a complete, prevention-first MSK pathway looks like in practice.

Download the full report to find out:

Over 60% of employees report MSK symptoms, with women disproportionately affected.
Employers are facing sustained PMI increases (up to 17% annually), rising absence, and hidden productivity loss driven by untreated or late-stage pain.
Many employers, particularly those with higher PMI utilisation, are facing 15–30% premium hikes at renewal.